D64.81

Anemia due to antineoplastic chemotherapy

Billable code

This code does not map to a risk-adjusting HCC in the loaded models.

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

This code · D64.81

Excludes 2

anemia in neoplastic disease (D63.0) aplastic anemia due to antineoplastic chemotherapy (D61.1)

Synonyms

Antineoplastic chemotherapy induced anemia

Inherited from D64Other anemias

Excludes 1

refractory anemia (D46.-) refractory anemia with excess blasts in transformation [RAEB T] (C92.0-)

Inherited from chapter 3Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Excludes 2

autoimmune disease (systemic) NOS (M35.9) certain conditions originating in the perinatal period (P00-P96) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) human immunodeficiency virus [HIV] disease (B20) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

Official Guidelines for D64.81

FY 2026 ›

I.C.3Chapter-specific guidanceChapter 3: Disease of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)

Find D64.81 in the alphabetic index

2 index paths lead to this code